Sugi Predict

Sugi Predict / Compounds / Edotreotide

Edotreotide

Edotreotide

SCHEMBL1649285

C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)CSSC[C@@H](C(=O)N[C@H](CO)[C@@H](C)O)NC1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ SSTR2 P30874 15/20 1.00
▸ SSTR5 P35346 7/20 1.00
▸ SSTR3 P32745 5/20 1.00
▸ SSTR4 P31391 10/20 0.95
▸ SSTR1 P30872 2/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Edotreotide SCHEMBL24087491 1.00 SSTR2 (1.00) SSTR2SSTR5SSTR3SSTR4SSTR1
Edotreotide SCHEMBL19712197 1.00 SSTR2 (1.00) SSTR2SSTR5SSTR3SSTR4SSTR1
Edotreotide SCHEMBL21652492 1.00 SSTR2 (1.00) SSTR2SSTR5SSTR3SSTR4SSTR1
Edotreotide SCHEMBL25448984 1.00 SSTR2 (1.00) SSTR2SSTR5SSTR3SSTR4SSTR1
Edotreotide SCHEMBL25448975 1.00 SSTR2 (1.00) SSTR2SSTR5SSTR3SSTR4SSTR1
SCHEMBL24828846 0.97 SSTR2 (0.94) SSTR2SSTR5SSTR3SSTR4SSTR1
SCHEMBL30151657 0.97 SSTR2 (0.94) SSTR2SSTR5SSTR3SSTR4SSTR1
Edotreotide SCHEMBL29760280 0.96 SSTR2 (0.92) SSTR2SSTR5SSTR3SSTR4SSTR1
Edotreotide SCHEMBL29533812 0.96 SSTR2 (0.92) SSTR2SSTR5SSTR3SSTR4SSTR1
Edotreotide SCHEMBL29376309 0.96 SSTR2 (0.92) SSTR2SSTR5SSTR3SSTR4SSTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12466851-B2 Manufacture of disulfide bonded peptides BACHEM HOLDING AG (CH) 2025-11-11 — — US disclosed
WO-2024110329-A1 LABELING OF BIOMOLECULES WITH ACTINIUM-225 AND MEDICAL USES THEREOF Technische Universität München (DE) 2024-05-30 — — WO disclosed
US-20220213139-A1 MANUFACTURE OF DISULFIDE BONDED PEPTIDES BACHEM HOLDING AG (CH) 2022-07-07 — — US disclosed
EP-3956343-A1 MANUFACTURE OF DISULFIDE BONDED PEPTIDES Bachem Holding AG (CH) 2022-02-23 — — EP disclosed
CN-114026107-A Production of disulfide peptides 巴克姆股份公司 2022-02-08 — — CN disclosed
WO-2020212477-A1 MANUFACTURE OF DISULFIDE BONDED PEPTIDES BACHEM HOLDING AG (CH) 2020-10-22 — — WO disclosed
EP-3257863-A1 FLOUROUS METABOLICALLY STABLE PEPTIDE ANALOGS Université de Strasbourg (FR) 2017-12-20 — — EP disclosed
US-7927613-B2 Pharmaceutical co-crystal compositions UNIVERSITY OF SOUTH FLORIDA (US) 2011-04-19 — — US disclosed
US-7790905-B2 Pharmaceutical propylene glycol solvate compositions MCNEIL-PPC, INC. (US) 2010-09-07 — — US disclosed